Trial Profile
A phase IIa multicentre randomised double-blind, double-dummy study to evaluate the efficacy and safety of K-111 versus Fenofibrate in patients with hyperlipidaemia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jul 2011
Price :
$35
*
At a glance
- Drugs K 111 (Primary) ; Fenofibrate
- Indications Hyperlipidaemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Kowa
- 23 Jul 2011 New trial record